UK markets closed

Anxo Pharmaceutical Co., Ltd. (6677.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
45.85+0.50 (+1.10%)
At close: 02:23PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
939,944
939,944
866,274
824,100
866,110
Cost of revenue
543,010
543,010
534,816
492,441
509,816
Gross profit
396,934
396,934
331,458
331,659
356,294
Operating expenses
Research development
139,203
139,203
139,589
111,381
100,562
Selling general and administrative
204,578
204,578
185,659
180,431
198,610
Total operating expenses
343,781
343,781
325,248
291,812
299,172
Operating income or loss
53,153
53,153
6,210
39,847
57,122
Interest expense
18,075
18,075
15,193
12,762
14,189
Income before tax
38,680
38,680
-4,714
24,327
48,911
Income tax expense
7,882
7,882
2,327
4,586
10,304
Income from continuing operations
30,798
30,798
-7,041
19,741
38,607
Net income
21,861
21,861
-12,558
19,234
31,404
Net income available to common shareholders
21,861
21,861
-12,558
19,234
31,404
Basic EPS
0.68
-
-0.26
0.39
0.63
Diluted EPS
0.67
-
-0.26
0.39
0.63
Basic average shares
49,939
-
48,300
49,939
49,817
Diluted average shares
50,429
-
48,300
50,268
49,830